The global market for peptide-based cancer therapies is rapidly expanding, offering new therapeutic and diagnostic opportunities. Peptides, known for their high specificity and minimized toxicity, ...

A new report by FutureWise Research highlights a powerful trend in modern medicine: as awareness and innovation rise, hope ...

A panelist discusses how the CABINET trial showed significant progression-free survival benefits for cabozantinib compared with placebo (particularly in pancreatic neuroendocrine tumors (NETs), why ...

Radioligand therapy, also know as radiopharmaceutical therapy, involves attaching a radioactive isotope to a targeting molecule that is injected into the bloodstream. This molecule binds to specific ...

They share the latest recommendations on managing symptoms related to hormone excess, including carcinoid syndrome and carcinoid heart disease, managing symptoms of functioning pancreatic ...

The cells targeted the cancer and eradicated it. Thirteen years later, Whitehead is still cancer-free. Since then, however, ...

ZL-1310 earns fast track designation in extensive-stage small cell lung cancer after early trial data showed tumor shrinkage ...

A panelist discusses how neuroendocrine tumors are defined by World Health Organization (WHO) classification, graded based on Ki-67 proliferative index, diagnosed through imaging (often incidentally), ...

South Korea has received approval for domestic production and supply of radioisotopes Actinium(Ac-225) and Iodine (I-131) used for cancer treatment, after long depending ...